112 related articles for article (PubMed ID: 17697201)
1. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?
Talley NJ; Vakil N; Lauritsen K; van Zanten SV; Flook N; Bolling-Sternevald E; Persson T; Björck E; Lind T;
Aliment Pharmacol Ther; 2007 Sep; 26(5):673-82. PubMed ID: 17697201
[TBL] [Abstract][Full Text] [Related]
2. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.
van Zanten SV; Flook N; Talley NJ; Vakil N; Lauritsen K; Bolling-Sternevald E; Persson T; Björck E; Svedberg LE;
Aliment Pharmacol Ther; 2007 Sep; 26(5):665-72. PubMed ID: 17697200
[TBL] [Abstract][Full Text] [Related]
3. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.
van Zanten SV; Armstrong D; Chiba N; Flook N; White RJ; Chakraborty B; Gasco A
Am J Gastroenterol; 2006 Sep; 101(9):2096-106. PubMed ID: 16817845
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs.
Hawkey CJ; Jones RH; Yeomans ND; Scheiman JM; Talley NJ; Goldstein JL; Ahlbom H; Naesdal J
Aliment Pharmacol Ther; 2007 Apr; 25(7):813-21. PubMed ID: 17373920
[TBL] [Abstract][Full Text] [Related]
5. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
[TBL] [Abstract][Full Text] [Related]
6. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors.
Hawkey C; Talley NJ; Yeomans ND; Jones R; Sung JJ; Långström G; Naesdal J; Scheiman JM;
Am J Gastroenterol; 2005 May; 100(5):1028-36. PubMed ID: 15842575
[TBL] [Abstract][Full Text] [Related]
7. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
8. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.
van Zanten SV; Wahlqvist P; Talley NJ; Halling K; Vakil N; Lauritsen K; Flook N; Persson T; Bolling-Sternevald E;
Aliment Pharmacol Ther; 2011 Oct; 34(7):714-23. PubMed ID: 21848799
[TBL] [Abstract][Full Text] [Related]
9. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
Gold BD; Gunasekaran T; Tolia V; Wetzler G; Conter H; Traxler B; Illueca M
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):520-9. PubMed ID: 18030228
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: identification of responders to short-term treatment with esomeprazole for dyspepsia in primary care - a randomised, placebo-controlled study.
Meineche-Schmidt V; Christensen E; Bytzer P
Aliment Pharmacol Ther; 2011 Jan; 33(1):41-9. PubMed ID: 21083590
[TBL] [Abstract][Full Text] [Related]
12. Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial.
Flook NW; Moayyedi P; Dent J; Talley NJ; Persson T; Karlson BW; Ruth M
Am J Gastroenterol; 2013 Jan; 108(1):56-64. PubMed ID: 23147520
[TBL] [Abstract][Full Text] [Related]
13. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
[TBL] [Abstract][Full Text] [Related]
15. Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Am J Gastroenterol; 2012 Sep; 107(9):1354-60. PubMed ID: 22777339
[TBL] [Abstract][Full Text] [Related]
16. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):612-9. PubMed ID: 22343515
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
20. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]